TABLE 2.
Group | Chicken no. | Result (fecal/serum) at week p.i.:
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | ||
A (aHVRd1) | 5357 | −/− | −/− | −/− | −/− | −/− | −/− | +/− | −/− | −/− |
5361 | −/− | −/− | −/− | +/− | −/− | −/− | +/− | −/− | −/− | |
5368 | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | |
B (aHVRd2) | 5353 | −/− | −/− | −/− | +/+ | −/− | −/− | −/− | −/− | +/− |
5372 | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | |
5388 | −/− | −/− | +/− | +/+ | −/+ | −/+ | −/+ | −/− | −/− | |
C (aHVRd3) | 5354 | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− |
5355 | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | |
5385 | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | |
D (wild-type clone) (positive control group) | 5362 | −/− | −/− | +/− | +/+ | −/− | −/− | −/− | −/− | −/− |
5367 | −/− | −/− | − | −/− | +/− | −/− | −/− | −/− | −/− | |
5374 | −/− | −/− | −/+ | +/+ | −/− | −/− | −/− | −/− | −/− | |
E (negative control group) | 5352 | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− |
5358 | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | |
5369 | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− | −/− |
Positive (+) or negative (−) samples at the indicated week p.i. in SPF chickens intrahepatically inoculated with capped RNA transcripts of avian HEV HVR deletion mutants, as well as the wild-type avian HEV infectious clone.